8-K
filed July 21, 2026, 4:10 PM ET
ticker RBOT
CIK 0001812173
other material
confidence high
sentiment negative
materiality 1.00
Vicarious Surgical to liquidate via assignment for benefit of creditors; stockholders likely receive nothing
Vicarious Surgical Inc.
- Stockholders approved assignment for benefit of creditors and voluntary dissolution at July 21 special meeting; 13.3M votes for, 100.9K against.
- All directors resigned effective upon filing Form 15 to deregister common stock; CEO, President, CTO, CMO terminated with severance (CEO $672,699, President $779,190, CTO $611,261).
- Company will file Form 15 to deregister common stock due to fewer than 300 holders of record; expects deregistration effective 90 days after filing.
- Creditors have priority over stockholders; stockholders are not expected to receive any distribution from assigned assets.
- Assignment Agreement transfers all assignable assets to Vicarious Liquidation, LLC for benefit of creditors; contracts and employee benefit plans excluded.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Victoria Carr-Brendel resigned as Director at Vicarious Surgical Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Sammy Khalifa resigned as Director at Vicarious Surgical Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Stephen From was terminated as Chief Executive Officer at Vicarious Surgical Inc..
- Action
- terminated
- Role
- Chief Executive Officer
Exact text from the filing
the Company terminated the employment of each of Stephen From, the Company’s Chief Executive Officer, Adam Sachs, the Company’s President, Sammy Khalifa, the Company’s Chief Technology Officer, and Dr. Barry Greene, the Company’s Chief Medical Officer, effective as of the close of business on July 21, 2026.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Sammy Khalifa was terminated as Chief Technology Officer at Vicarious Surgical Inc..
- Action
- terminated
- Role
- Chief Technology Officer
Exact text from the filing
the Company terminated the employment of each of Stephen From, the Company’s Chief Executive Officer, Adam Sachs, the Company’s President, Sammy Khalifa, the Company’s Chief Technology Officer, and Dr. Barry Greene, the Company’s Chief Medical Officer, effective as of the close of business on July 21, 2026.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Adam Sachs resigned as Director at Vicarious Surgical Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
David Ho resigned as Director at Vicarious Surgical Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Stephen From resigned as Director at Vicarious Surgical Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Fuad Ahmad resigned as Director at Vicarious Surgical Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Dr. Barry Greene was terminated as Chief Medical Officer at Vicarious Surgical Inc..
- Action
- terminated
- Role
- Chief Medical Officer
Exact text from the filing
the Company terminated the employment of each of Stephen From, the Company’s Chief Executive Officer, Adam Sachs, the Company’s President, Sammy Khalifa, the Company’s Chief Technology Officer, and Dr. Barry Greene, the Company’s Chief Medical Officer, effective as of the close of business on July 21, 2026.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Adam Sachs was terminated as President at Vicarious Surgical Inc..
- Action
- terminated
- Role
- President
Exact text from the filing
the Company terminated the employment of each of Stephen From, the Company’s Chief Executive Officer, Adam Sachs, the Company’s President, Sammy Khalifa, the Company’s Chief Technology Officer, and Dr. Barry Greene, the Company’s Chief Medical Officer, effective as of the close of business on July 21, 2026.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Joseph Doherty resigned as Director at Vicarious Surgical Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.